ALKS 4230

Esmo 2020 – can Alkermes succeed where Nektar failed?
EP Vantage
Wed, 09/23/20 - 10:33 am
Alkermes
ESMO
ALKS 4230
melanoma
ESMO: Alkermes' major I-O hope sees progress across early cancer tests
Fierce Biotech
Fri, 09/18/20 - 11:09 am
Alkermes
immuno-oncology
ESMO
ALKS 4230
Keytruda